Burnett Patrick bought ARQT
July 10, 2025 · Form 4 insider transaction
Burnett Patrick bought 23,000 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
23,000
Price
$0.00
Total value
N/A
InsiderBurnett Patrick
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 10, 2025
Filing dateJuly 14, 2025
Shares owned after138,468
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026.